BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30810811)

  • 1. Caspase-4 mediates cytoplasmic accumulation of TDP-43 in the primate brains.
    Yin P; Guo X; Yang W; Yan S; Yang S; Zhao T; Sun Q; Liu Y; Li S; Li XJ
    Acta Neuropathol; 2019 Jun; 137(6):919-937. PubMed ID: 30810811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic mislocalization of RNA splicing factors and aberrant neuronal gene splicing in TDP-43 transgenic pig brain.
    Wang G; Yang H; Yan S; Wang CE; Liu X; Zhao B; Ouyang Z; Yin P; Liu Z; Zhao Y; Liu T; Fan N; Guo L; Li S; Li XJ; Lai L
    Mol Neurodegener; 2015 Sep; 10():42. PubMed ID: 26334913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both cytoplasmic and nuclear accumulations of the protein are neurotoxic in Drosophila models of TDP-43 proteinopathies.
    Miguel L; Frébourg T; Campion D; Lecourtois M
    Neurobiol Dis; 2011 Feb; 41(2):398-406. PubMed ID: 20951205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoplasmic TDP-43 impairs the activity of the ubiquitin-proteasome system.
    Yin P; Bai D; Zhu L; Deng F; Guo X; Li B; Chen L; Li S; Li XJ
    Exp Neurol; 2021 Nov; 345():113833. PubMed ID: 34363810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic mice.
    Medina DX; Orr ME; Oddo S
    Neurobiol Aging; 2014 Jan; 35(1):79-87. PubMed ID: 23954172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent phenotypes in mutant TDP-43 transgenic mice highlight potential confounds in TDP-43 transgenic modeling.
    D'Alton S; Altshuler M; Cannon A; Dickson DW; Petrucelli L; Lewis J
    PLoS One; 2014; 9(1):e86513. PubMed ID: 24466128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplex SILAC analysis of a cellular TDP-43 proteinopathy model reveals protein inclusions associated with SUMOylation and diverse polyubiquitin chains.
    Seyfried NT; Gozal YM; Dammer EB; Xia Q; Duong DM; Cheng D; Lah JJ; Levey AI; Peng J
    Mol Cell Proteomics; 2010 Apr; 9(4):705-18. PubMed ID: 20047951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor-Coordinative and Cognitive Dysfunction Caused by Mutant TDP-43 Could Be Reversed by Inhibiting Its Mitochondrial Localization.
    Wang W; Arakawa H; Wang L; Okolo O; Siedlak SL; Jiang Y; Gao J; Xie F; Petersen RB; Wang X
    Mol Ther; 2017 Jan; 25(1):127-139. PubMed ID: 28129109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PABPN1 suppresses TDP-43 toxicity in ALS disease models.
    Chou CC; Alexeeva OM; Yamada S; Pribadi A; Zhang Y; Mo B; Williams KR; Zarnescu DC; Rossoll W
    Hum Mol Genet; 2015 Sep; 24(18):5154-73. PubMed ID: 26130692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43.
    Uchida A; Sasaguri H; Kimura N; Tajiri M; Ohkubo T; Ono F; Sakaue F; Kanai K; Hirai T; Sano T; Shibuya K; Kobayashi M; Yamamoto M; Yokota S; Kubodera T; Tomori M; Sakaki K; Enomoto M; Hirai Y; Kumagai J; Yasutomi Y; Mochizuki H; Kuwabara S; Uchihara T; Mizusawa H; Yokota T
    Brain; 2012 Mar; 135(Pt 3):833-46. PubMed ID: 22252998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS.
    Ke YD; van Hummel A; Stevens CH; Gladbach A; Ippati S; Bi M; Lee WS; Krüger S; van der Hoven J; Volkerling A; Bongers A; Halliday G; Haass NK; Kiernan M; Delerue F; Ittner LM
    Acta Neuropathol; 2015 Nov; 130(5):661-78. PubMed ID: 26437864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tunicamycin produces TDP-43 cytoplasmic inclusions in cultured brain organotypic slices.
    Leggett C; McGehee DS; Mastrianni J; Yang W; Bai T; Brorson JR
    J Neurol Sci; 2012 Jun; 317(1-2):66-73. PubMed ID: 22459357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TDP-43 causes differential pathology in neuronal versus glial cells in the mouse brain.
    Yan S; Wang CE; Wei W; Gaertig MA; Lai L; Li S; Li XJ
    Hum Mol Genet; 2014 May; 23(10):2678-93. PubMed ID: 24381309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins.
    Ratti A; Buratti E
    J Neurochem; 2016 Aug; 138 Suppl 1():95-111. PubMed ID: 27015757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SQSTM1-mediated clearance of cytoplasmic mutant TARDBP/TDP-43 in the monkey brain.
    Yin P; Bai D; Deng F; Zhang C; Jia Q; Zhu L; Chen L; Li B; Guo X; Ye J; Tan Z; Wang L; Li S; Li XJ
    Autophagy; 2022 Aug; 18(8):1955-1968. PubMed ID: 34936539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TARDBP pathogenic mutations increase cytoplasmic translocation of TDP-43 and cause reduction of endoplasmic reticulum Ca²⁺ signaling in motor neurons.
    Mutihac R; Alegre-Abarrategui J; Gordon D; Farrimond L; Yamasaki-Mann M; Talbot K; Wade-Martins R
    Neurobiol Dis; 2015 Mar; 75():64-77. PubMed ID: 25526708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic accumulation and aggregation of TDP-43 upon proteasome inhibition in cultured neurons.
    van Eersel J; Ke YD; Gladbach A; Bi M; Götz J; Kril JJ; Ittner LM
    PLoS One; 2011; 6(7):e22850. PubMed ID: 21829535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal regenerative responses and impaired axonal outgrowth after nerve crush in TDP-43 transgenic mouse models of amyotrophic lateral sclerosis.
    Swarup V; Audet JN; Phaneuf D; Kriz J; Julien JP
    J Neurosci; 2012 Dec; 32(50):18186-95. PubMed ID: 23238732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TDP-43 proteinopathy in ALS is triggered by loss of ASRGL1 and associated with HML-2 expression.
    Garcia-Montojo M; Fathi S; Rastegar C; Simula ER; Doucet-O'Hare T; Cheng YHH; Abrams RPM; Pasternack N; Malik N; Bachani M; Disanza B; Maric D; Lee MH; Wang H; Santamaria U; Li W; Sampson K; Lorenzo JR; Sanchez IE; Mezghrani A; Li Y; Sechi LA; Pineda S; Heiman M; Kellis M; Steiner J; Nath A
    Nat Commun; 2024 May; 15(1):4163. PubMed ID: 38755145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of TDP-43 mediates severe neurotoxicity by suppressing PJA1 gene transcription in the monkey brain.
    Zhu L; Deng F; Bai D; Hou J; Jia Q; Zhang C; Ou K; Li S; Li XJ; Yin P
    Cell Mol Life Sci; 2024 Jan; 81(1):16. PubMed ID: 38194085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.